查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496165

经皮血管成形术 (PTA) 全球市场（2024 年版）：按产品类型、应用、最终用户和地区、市场洞察和预测进行分析（2020-2030 年）

Global Percutaneous Transluminal Angioplasty (PTA) Market (2024 Edition): Analysis By Product Type (Balloon Catheters, Stents, Guidewires, Others), By Application, By End User, By Region: Market Insights and Forecast (2020-2030)
出版日期: | 出版商: Azoth Analytics | 英文 252 Pages | 订单完成后即时交付

价格

2020-2023年全球经皮血管成形术（PTA）市场规模复合年增长率为10.25%。 2023年市场规模为29.2亿美元，预计2030年将达69.5亿美元。该市场的推动因素包括心血管疾病盛行率上升、技术进步、人口老化、意识增强、医疗基础设施改善、有利的报销政策、微创手术的采用增加、医疗保健成本上升、医疗旅游，这是由战略性产业合作和其他因素。

根据世界心臟联合会统计，全球仍有超过5亿人患有心血管疾病，预计2021年死亡人数将达到2,050万人，占全球整体。心血管疾病，包括冠状动脉疾病、周边动脉疾病和心律不整，仍是全世界发病和死亡的主要原因。心血管疾病的快速增加对有效的微创治疗方案（如 PTA）产生了巨大的需求，这种治疗方案无需进行大手术即可恢復阻塞或狭窄动脉的血流。

人们对微创选择的认识不断提高，导致患者对 PTA 等手术的需求增加。患者通常更喜欢微创手术，因为它可以减少疼痛、减少疤痕并缩短恢復时间。此外，医疗保健提供者越来越多地采用 PTA 等微创技术作为 CVD 管理的标准做法。医疗技术和程序的进步使 PTA 程序更安全、更有效、更容易执行，并且正在获得临床医生的认可。

药物涂层球囊 (DCB) 技术是经经皮血管成形术 (PTA) 球囊导管的重大进步。这些球囊涂有抗增殖药物，例如紫杉醇或Sirolimus，在膨胀时会局部释放到动脉壁。与传统的无涂层球囊相比，这种标靶药物传输可抑制平滑肌细胞增生并抑制新内膜增生，进而改善长期血管通畅性。 DCB 已证明可以有效降低血管再阻塞率和重复干预的需要，特别是在复杂病变和小血管中。该技术是一种很有前途的方法，可以透过解决血管再阻塞（与血管成形术相关的主要挑战之一）来改善 PTA 手术的结果。

血管内超音波（IVUS）和光同调断层扫瞄（OCT）等先进影像设备在增强周边动脉疾病（PAD）的治疗方面发挥重要作用。 IVUS 和 OCT 提供週边动脉的高解析度影像，可实现准确的病变评估和治疗计划。透过在 PTA 手术期间提供即时指导，IVUS 和 OCT 可以帮助优化球囊尺寸、支架放置和后扩张手术，从而改善 PAD 患者的手术结果并降低併发症的发生率。该功能是 PAD 治疗的重大进步，为临床医生提供了宝贵的工具，以提高全球 PTA 市场的手术精度和患者照护。

精准医学和个人化治疗的进步旨在根据患者个体特征（包括遗传倾向、疾病表型和反应概况）来客製 PTA 治疗。生物标记引导的干预措施、针对患者的治疗流程和标靶药物传输系统为优化治疗结果并最大限度地减少 PTA 手术中的不利事件提供了机会。

该报告审视了全球经皮血管成形术 (PTA) 市场，并提供了包括市场规模和预测、区域和细分市场分析以及主要趋势和机会在内的资讯。

目录

第一章 市集背景

  • 产品范围和产品前景
  • 执行摘要
  • 调查方法

第二章 战略建议

  • 联合治疗的有效性研究
  • 提高开发中国家对低成本治疗方法的普及

第三章全球经皮血管成形术（PTA）市场：表现与预测

  • 宏观经济因素对全球经皮皮血管成形术（PTA）市场的影响分析
  • 流行病学：全球慢性病的盛行率
  • 流行病学：慢性病的全球盛行率
  • 全球经皮血管成形术 (PTA) 市场：市场规模和复合年增长率（2020-2030）
  • COVID-19 对经皮血管成形术 (PTA) 市场的影响
  • 全球经皮血管成形术 (PTA) 市场细分：按产品类型
    • 全球经皮血管成形术 (PTA) 市场：依产品类型、概述
    • 全球经皮血管成形术 (PTA) 市场吸引力指数：依产品类型、概述
    • 全球经皮血管成形术（PTA）市场规模：球囊导管（金额）（2020-2030）
    • 全球经皮血管成形术（PTA）市场规模：支架（金额）（2020-2030）
    • 全球经皮血管成形术（PTA）市场规模： 导管导引线（金额）（2020-2030）
    • 全球经皮血管成形术（PTA）市场规模：其他（金额）（2020-2030）
  • 全球经皮血管成形术 (PTA) 市场区隔：按应用
    • 全球经皮血管成形术 (PTA) 市场：按应用、概述
    • 全球经皮血管成形术 (PTA) 市场吸引力指数：按应用、概述
    • 全球经皮血管成形术（PTA）市场规模：冠状动脉疾病（金额）（2020-2030）
    • 全球经皮血管成形术（PTA）市场规模：周边动脉疾病（金额）（2020-2030）
  • 全球经皮血管成形术 (PTA) 市场细分：按最终用户
    • 全球经皮血管成形术 (PTA) 市场概述：按最终用户分类
    • 全球经皮血管成形术 (PTA) 市场吸引力指数：按最终用户划分，概述
    • 全球经皮血管成形术（PTA）市场规模：医院（金额）（2020-2030）
    • 全球经皮血管成形术 (PTA) 市场规模：门诊手术中心（金额）（2020-2030）
    • 全球经皮血管成形术（PTA）市场规模：专科诊所（金额）（2020-2030）

第四章全球经皮血管成形术 (PTA) 市场、区域分析

  • 研究的区域范围
  • 区域简介

第五章美洲经皮血管成形术 (PTA) 市场：表现与预测

  • 美洲经皮血管成形术 (PTA) 市场：概述
  • 美洲经皮血管成形术 (PTA) 市场：市场规模和复合年增长率（2020-2030）
  • 美洲经皮血管成形术 (PTA) 市场：主要驱动因素
  • 美洲经皮血管成形术 (PTA) 市场：細項分析
  • 按产品类型分類的美洲经皮血管成形术 (PTA) 市场细分
  • 美洲经皮血管成形术 (PTA) 市场区隔：按应用
  • 按最终用户分類的美洲经皮血管成形术 (PTA) 市场细分
  • 美洲经皮血管成形术 (PTA) 市场细分：按国家/地区
    • 欧洲经皮血管成形术 (PTA) 市场：按国家/地区、概述
    • 美国经皮血管成形术 (PTA) 市场：市场规模和复合年增长率（2020-2030）
    • 加拿大经经皮血管成形术 (PTA) 市场：市场规模和复合年增长率（2020-2030）
    • 其他美洲经皮血管成形术 (PTA) 市场：市场规模和复合年增长率 (2020-2030)

第六章欧洲经皮皮血管成形术（PTA）市场：表现与预测

  • 欧洲经皮血管成形术 (PTA) 市场：概况
  • 欧洲经皮皮血管成形术 (PTA) 市场：市场规模与复合年增长率（2020-2030）
  • 欧洲经皮血管成形术 (PTA) 市场：主要驱动因素
  • 欧洲经皮血管成形术（PTA）市场：細項分析
  • 欧洲经皮血管成形术 (PTA) 市场细分：按产品类型
  • 欧洲经皮血管成形术 (PTA) 市场细分：按应用
  • 欧洲经皮血管成形术 (PTA) 市场细分：按最终用户
  • 欧洲经皮血管成形术 (PTA) 市场细分：按国家/地区
    • 欧洲经皮血管成形术 (PTA) 市场：按国家/地区、概述
    • 英国经皮皮血管成形术 (PTA) 市场：市场规模与复合年增长率（2020-2030）
    • 德国经皮皮血管成形术 (PTA) 市场：市场规模和复合年增长率（2020-2030）
    • 法国经皮皮血管成形术 (PTA) 市场：市场规模和复合年增长率（2020-2030）
    • 西班牙经经皮血管成形术 (PTA) 市场：市场规模和复合年增长率（2020-2030）
    • 其他欧洲经皮皮血管成形术（PTA）市场：市场规模和复合年增长率（2020-2030）

第七章亚太经经皮血管成形术（PTA）市场：表现与预测

  • 亚太地区经皮血管成形术 (PTA) 市场：概况
  • 亚太地区经皮皮血管成形术 (PTA) 市场：市场规模和复合年增长率（2020-2030）
  • 亚太地区经皮血管成形术 (PTA) 市场：主要驱动因素
  • 亚太地区经皮血管成形术 (PTA) 市场：細項分析
  • 亚太地区经皮血管成形术 (PTA) 市场细分：按产品类型
  • 亚太地区经皮血管成形术 (PTA) 市场区隔：按应用
  • 亚太地区经皮血管成形术 (PTA) 市场细分：按最终用户划分
  • 亚太地区经皮血管成形术 (PTA) 市场细分：按国家/地区
    • 亚太地区经皮血管成形术 (PTA) 市场：按国家/地区划分，概述
    • 中国经皮血管成形术（PTA）市场：市场规模及复合年增长率（2020-2030）
    • 日本经皮血管成形术（PTA）市场：市场规模与复合年增长率（2020-2030）
    • 印度经皮皮血管成形术 (PTA) 市场：市场规模和复合年增长率（2020-2030）
    • 韩国经经皮血管成形术 (PTA) 市场：市场规模和复合年增长率（2020-2030）
    • 其他亚太地区经皮皮血管成形术 (PTA) 市场：市场规模和复合年增长率（2020-2030）

第 8 章中东和非洲经经皮血管成形术 (PTA) 市场：表现和预测

  • 中东和非洲经经皮血管成形术 (PTA) 市场：简介
  • 中东和非洲经经皮血管成形术 (PTA) 市场：市场规模和复合年增长率（2020-2030）
  • 中东和非洲经经皮血管成形术 (PTA) 市场：主要驱动因素
  • 中东和非洲经经皮血管成形术 (PTA) 市场：細項分析
  • 中东和非洲经皮血管成形术 (PTA) 市场细分：按产品类型
  • 中东和非洲经皮血管成形术 (PTA) 市场细分：按应用
  • 中东和非洲经皮血管成形术 (PTA) 市场按最终用户细分

第九章市场动态

  • 评估市场动态对全球经皮皮血管成形术 (PTA) 市场的影响
  • 促进因素
  • 抑制因素
  • 趋势

第10章产业生态系分析

  • 波特分析

第十一章竞争定位

  • 企业产品定位
  • 主要企业市场占有率
  • 公司简介
    • Medtronic PLC
    • Terumo Corporation
    • Cardinal Health, Inc
    • Boston Scientific
    • Teleflex Incorporated
    • Johnson & Johnson
    • Abbott Laboratories
    • Stryker Corporation
    • Becton Dickinson and Co
    • Cook Group Inc.

第十二章 关于我们公司、免责声明

Executive Summary

Azoth Analytics has released a research report titled "Global Percutaneous Transluminal Angioplasty (PTA) Market (2024 Edition)" which provides a complete analysis of the Global Percutaneous Transluminal Angioplasty (PTA) industry in terms of market segmentation by Product Type (Balloon Catheters, Stents, Guidewires Others), by Application (Coronary Artery Disease, Peripheral Artery Disease), by End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, United Kingdom, Germany, France, Spain, China, India, Japan, South Korea). The Global Percutaneous Transluminal Angioplasty (PTA) market showcased growth at a CAGR of 10.25% during 2020-2023. The market was valued at USD 2.92 Billion in 2023 which is expected to reach USD 6.95 Billion in 2030. The global percutaneous transluminal angioplasty (PTA) market is driven by the rising prevalence of cardiovascular diseases, technological advancements, an aging population, growing awareness, improved healthcare infrastructure, favorable reimbursement policies, increased adoption of minimally invasive procedures, rising healthcare expenditure, medical tourism, and strategic industry collaboration.

According to World Heart Federation, more than half a billion people around the world continue to be affected by cardiovascular diseases, which accounted for 20.5 million deaths in 2021- close to a third of all deaths globally and an overall increase on the estimated 121 million CVD deaths. Cardiovascular diseases, including coronary artery disease, peripheral artery disease, and cardiac arrhythmias, continue to be leading causes of morbidity and mortality globally. This surge in cardiovascular conditions creates a greater demand for effective, minimally invasive treatment options like PTA, which restore blood flow in blocked or narrowed arteries without the need for major surgery.

The growing awareness of minimally invasive options has led to increased patient demand for procedures like PTA. Patients often prefer minimally invasive techniques due to their perceived advantages, including reduced pain, scarring, and recovery time. Also, Healthcare providers are increasingly adopting minimally invasive techniques like PTA as standard practice in the management of CVDs. Advances in medical technology and techniques have made PTA procedures safer, more effective, and easier to perform, leading to greater acceptance among clinicians.

Drug-coated balloon (DCB) technology represents a significant advancement in balloon catheters for percutaneous transluminal angioplasty (PTA). These balloons are coated with anti-proliferative drugs, such as paclitaxel or sirolimus, which are released locally into the arterial wall during inflation. This targeted drug delivery helps to inhibit smooth muscle cell proliferation and reduce neointimal hyperplasia, thereby improving long-term vessel patency compared to traditional uncoated balloons. DCBs have demonstrated efficacy in reducing restenosis rates and the need for repeat interventions, particularly in complex lesions or small vessels. This technology offers a promising approach to improving the outcomes of PTA procedures by addressing one of the primary challenges associated with angioplasty-restenosis.

Advanced imaging modalities, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), play a crucial role in enhancing the treatment of peripheral artery disease (PAD). IVUS and OCT provide high-resolution imaging of peripheral arteries, allowing for precise lesion assessment and treatment planning. By offering real-time guidance during PTA procedures, IVUS and OCT help optimize balloon sizing, stent placement, and post-dilation techniques, leading to improved procedural outcomes and reduced rates of complications in PAD patients. This feature represents a significant advancement in the treatment of PAD, providing clinicians with invaluable tools to enhance procedural precision and patient care in the global PTA market.

Advancements in precision medicine and personalized therapies aim to tailor PTA treatments to individual patient characteristics, including genetic predispositions, disease phenotypes, and response profiles. Biomarker-guided interventions, patient-specific treatment algorithms, and targeted drug delivery systems offer opportunities to optimize treatment outcomes and minimize adverse events in PTA procedures.

Scope of the Report:

  • The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Value (USD Million).
  • The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Epidemiology.
  • The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, United Kingdom, Germany, France, Spain, China, India, Japan, South Korea).
  • The report presents the analysis of Percutaneous Transluminal Angioplasty (PTA) Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
  • The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Product Type (Balloon Catheters, Stents, Guidewires, Others).
  • The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Application (Coronary Artery Disease, Peripheral Artery Disease).
  • The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by product type, by application, & by end user.
  • Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Medtronic PLC, Terumo Corporation, Cardinal Health, Boston Scientific, Teleflex Incorporated, Johnson & Johnson, Abbott Laboratories, Stryker Corporation, Becton Dickinson and Co, and Cook Group Inc.

Table of Contents

1. Market Background

  • 1.1 Scope and Product Outlook
  • 1.2 Executive Summary
  • 1.3 Research Methodology

2. Strategic Recommendations

  • 2.1 Explore the availability of combination therapies
  • 2.2 Expand the prevalence of low cost therapies in developing countries

3. Global Percutaneous Transluminal Angioplasty (PTA) Market: Historic and Forecast

  • 3.1 Impact Analysis of Macro Economic Factors on Global Percutaneous Transluminal Angioplasty (PTA) Market
  • 3.2 Epidemiology: Global Chronic Disease Prevalence
  • 3.3 Epidemiology: Global Chronic Disease Incidence
  • 3.4 Global Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  • 3.5 Degree of Impact of Covid-19 on Percutaneous Transluminal Angioplasty (PTA) Market
  • 3.6 Global Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Product Type
    • 3.6.1 Global Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type Overview
    • 3.6.2 Global Percutaneous Transluminal Angioplasty (PTA) Market Attractiveness Index, By Product Type Overview
    • 3.6.3 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
    • 3.6.4 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
    • 3.6.5 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
    • 3.6.6 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Others, By Value, 2020H-2030F (USD Million & CAGR)
  • 3.7 Global Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Application
    • 3.7.1 Global Percutaneous Transluminal Angioplasty (PTA) Market, By Application Overview
    • 3.7.2 Global Percutaneous Transluminal Angioplasty (PTA) Market Attractiveness Index, By Application Overview
    • 3.7.3 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
    • 3.7.4 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • 3.8 Global Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By End User
    • 3.8.1 Global Percutaneous Transluminal Angioplasty (PTA) Market, By End User Overview
    • 3.8.2 Global Percutaneous Transluminal Angioplasty (PTA) Market Attractiveness Index, By End User Overview
    • 3.8.3 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
    • 3.8.4 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
    • 3.8.5 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)

4. Global Percutaneous Transluminal Angioplasty (PTA) Market, Region Analysis

  • 4.1 Regional Coverage of the Study
  • 4.2 Regional Snapshot

5. Americas Percutaneous Transluminal Angioplasty (PTA) Market: Historic and Forecast

  • 5.1 Americas Percutaneous Transluminal Angioplasty (PTA) Market: Snapshot
  • 5.2 Americas Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  • 5.3 Americas Percutaneous Transluminal Angioplasty (PTA) Market: Key Factors
  • 5.4 Americas Percutaneous Transluminal Angioplasty (PTA) Market: Segment Analysis
  • 5.5 Americas Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Product Type
    • 5.5.1 Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type Overview
    • 5.5.2 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
    • 5.5.3 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
    • 5.5.4 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
    • 5.5.5 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Others, By Value, 2020H-2030F (USD Million & CAGR)
  • 5.6 Americas Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Application
    • 5.6.1 Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Application Overview
    • 5.6.2 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
    • 5.6.3 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • 5.7 Americas Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By End User
    • 5.7.1 Americas Percutaneous Transluminal Angioplasty (PTA) Market, By End User Overview
    • 5.7.2 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
    • 5.7.3 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
    • 5.7.4 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
  • 5.8 Americas Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Country
    • 5.8.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Country Overview
    • 5.8.2 United States Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
      • 5.8.2.1 United States Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
      • 5.8.2.2 United States Percutaneous Transluminal Angioplasty (PTA) Market, By Application
      • 5.8.2.3 United States Percutaneous Transluminal Angioplasty (PTA) Market, By End User
    • 5.8.3 Canada Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
      • 5.8.3.1 Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
      • 5.8.3.2 Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Application
      • 5.8.3.3 Canada Percutaneous Transluminal Angioplasty (PTA) Market, By End User
    • 5.8.4 Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
      • 5.8.4.1 Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
      • 5.8.4.2 Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Application
      • 5.8.4.3 Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By End User

6. Europe Percutaneous Transluminal Angioplasty (PTA) Market: Historic and Forecast

  • 6.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market: Snapshot
  • 6.2 Europe Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  • 6.3 Europe Percutaneous Transluminal Angioplasty (PTA) Market: Key Factors
  • 6.4 Europe Percutaneous Transluminal Angioplasty (PTA) Market: Segment Analysis
  • 6.5 Europe Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Product Type
    • 6.5.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type Overview
    • 6.5.2 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
    • 6.5.3 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
    • 6.5.4 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
    • 6.5.5 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Others, By Value, 2020H-2030F (USD Million & CAGR)
  • 6.6 Europe Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Application
    • 6.6.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Application Overview
    • 6.6.2 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
    • 6.6.3 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • 6.7 Europe Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By End User
    • 6.7.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market, By End User Overview
    • 6.7.2 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
    • 6.7.3 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
    • 6.7.4 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
  • 6.8 Europe Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Country
    • 6.8.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Country Overview
    • 6.8.2 United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
      • 6.8.2.1 United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
      • 6.8.2.2 United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Application
      • 6.8.2.3 United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By End User
    • 6.8.3 Germany Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
      • 6.8.3.1 Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
      • 6.8.3.2 Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Application
      • 6.8.3.3 Germany Percutaneous Transluminal Angioplasty (PTA) Market, By End User
    • 6.8.4 France Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
      • 6.8.4.1 France Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
      • 6.8.4.2 France Percutaneous Transluminal Angioplasty (PTA) Market, By Application
      • 6.8.4.3 France Percutaneous Transluminal Angioplasty (PTA) Market, By End User
    • 6.8.5 Spain Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
      • 6.8.5.1 Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
      • 6.8.5.2 Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Application
      • 6.8.5.3 Spain Percutaneous Transluminal Angioplasty (PTA) Market, By End User
    • 6.8.6 Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
      • 6.8.6.1 Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
      • 6.8.6.2 Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Application
      • 6.8.6.3 Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By End User

7. Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Historic and Forecast

  • 7.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Snapshot
  • 7.2 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  • 7.3 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Key Factors
  • 7.4 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Segment Analysis
  • 7.5 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Product Type
    • 7.5.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type Overview
    • 7.5.2 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
    • 7.5.3 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
    • 7.5.4 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
    • 7.5.5 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Others, By Value, 2020H-2030F (USD Million & CAGR)
  • 7.6 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Application
    • 7.6.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Application Overview
    • 7.6.2 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
    • 7.6.3 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • 7.7 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By End User
    • 7.7.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By End User Overview
    • 7.7.2 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
    • 7.7.3 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
    • 7.7.4 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
  • 7.8 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Country
    • 7.8.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Country Overview
    • 7.8.2 China Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
      • 7.8.2.1 China Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
      • 7.8.2.2 China Percutaneous Transluminal Angioplasty (PTA) Market, By Application
      • 7.8.2.3 China Percutaneous Transluminal Angioplasty (PTA) Market, By End User
    • 7.8.3 Japan Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
      • 7.8.3.1 Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
      • 7.8.3.2 Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Application
      • 7.8.3.3 Japan Percutaneous Transluminal Angioplasty (PTA) Market, By End User
    • 7.8.4 India Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
      • 7.8.4.1 India Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
      • 7.8.4.2 India Percutaneous Transluminal Angioplasty (PTA) Market, By Application
      • 7.8.4.3 India Percutaneous Transluminal Angioplasty (PTA) Market, By End User
    • 7.8.5 South Korea Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
      • 7.8.5.1 South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
      • 7.8.5.2 South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Application
      • 7.8.5.3 South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By End User
    • 7.8.6 Rest of Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
      • 7.8.6.1 Rest of Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
      • 7.8.6.2 Rest of Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Application
      • 7.8.6.3 Rest of Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By End User

8. Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market: Historic and Forecast

  • 8.1 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market: Snapshot
  • 8.2 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  • 8.3 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market: Key Factors
  • 8.4 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market: Segment Analysis
  • 8.5 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Product Type
    • 8.5.1 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type Overview
    • 8.5.2 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
    • 8.5.3 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
    • 8.5.4 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
    • 8.5.5 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Others, By Value, 2020H-2030F (USD Million & CAGR)
  • 8.6 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Application
    • 8.6.1 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Application Overview
    • 8.6.2 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
    • 8.6.3 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • 8.7 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By End User
    • 8.7.1 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By End User Overview
    • 8.7.2 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
    • 8.7.3 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
    • 8.7.4 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)

9. Market Dynamics

  • 9.1 Impact assessment of Market Dynamics on Global Percutaneous Transluminal Angioplasty (PTA) Market
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Trends

10. Industry Ecosystem Analysis

  • 10.1 Porter Analysis

11. Competitive Positioning

  • 11.1 Companies' Product Positioning
  • 11.2 Market Share of Leading Companies
  • 11.3 Company Profiling
    • 11.3.1 Medtronic PLC
    • 11.3.2 Terumo Corporation
    • 11.3.3 Cardinal Health, Inc
    • 11.3.4 Boston Scientific
    • 11.3.5 Teleflex Incorporated
    • 11.3.6 Johnson & Johnson
    • 11.3.7 Abbott Laboratories
    • 11.3.8 Stryker Corporation
    • 11.3.9 Becton Dickinson and Co
    • 11.3.10 Cook Group Inc.

12. About Us and Disclaimer

List of Figures

  • Figure 1: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Value, 2020-2023 (USD Million)
  • Figure 2: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Value, 2024-2030 (USD Million)
  • Figure 3: Global Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, 2023 (%)
  • Figure 4: Market Attractiveness Analysis of Global Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type (2025-2030)
  • Figure 5: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 6: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 7: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 8: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Stents, 2020H-2030F (USD Million)
  • Figure 9: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 10: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Guidewires, 2020H-2030F (USD Million)
  • Figure 11: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Others, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 12: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Others, 2020H-2030F (USD Million)
  • Figure 13: Market Attractiveness Analysis of Global Percutaneous Transluminal Angioplasty (PTA) Market, By Application (2025-2030)
  • Figure 14: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 15: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Coronary Artery Disease, 2020H-2030F (USD Million)
  • Figure 16: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 17: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Peripheral Artery Disease, 2020H-2030F (USD Million)
  • Figure 18: Market Attractiveness Analysis of Global Percutaneous Transluminal Angioplasty (PTA) Market, By End User (2025-2030)
  • Figure 19: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 20: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Hospitals, 2020H-2030F (USD Million)
  • Figure 21: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 22: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Ambulatory Surgical Centers, 2020H-2030F (USD Million)
  • Figure 23: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 24: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Specialty Clinics, 2020H-2030F (USD Million)
  • Figure 25: Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Value, 2020H-2030F (USD Million)
  • Figure 26: Americas Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, 2023 (%)
  • Figure 27: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 28: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 29: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 30: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Others, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 31: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 32: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 33: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 34: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 35: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 36: United States Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 37: United States Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
  • Figure 38: United States Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
  • Figure 39: United States Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
  • Figure 40: United States Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
  • Figure 41: Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 42: Canada Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
  • Figure 43: Canada Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
  • Figure 44: Canada Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
  • Figure 45: Canada Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
  • Figure 46: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 47: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
  • Figure 48: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
  • Figure 49: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
  • Figure 50: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
  • Figure 51: Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Value, 2020H-2030F (USD Million)
  • Figure 52: Europe Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, 2023 (%)
  • Figure 53: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 54: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 55: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 56: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Others, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 57: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 58: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 59: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 60: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 61: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 62: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 63: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
  • Figure 64: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
  • Figure 65: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
  • Figure 66: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
  • Figure 67: Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 68: Germany Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
  • Figure 69: Germany Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
  • Figure 70: Germany Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
  • Figure 71: Germany Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
  • Figure 72: France Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 73: France Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
  • Figure 74: France Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
  • Figure 75: France Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
  • Figure 76: France Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
  • Figure 77: Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 78: Spain Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
  • Figure 79: Spain Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
  • Figure 80: Spain Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
  • Figure 81: Spain Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
  • Figure 82: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 83: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
  • Figure 84: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
  • Figure 85: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
  • Figure 86: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
  • Figure 87: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Value, 2020H-2030F (USD Million)
  • Figure 88: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, 2023 (%)
  • Figure 89: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 90: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 91: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 92: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Others, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 93: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 94: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 95: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 96: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 97: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 98: China Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 99: China Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
  • Figure 100: China Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
  • Figure 101: China Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
  • Figure 102: China Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
  • Figure 103: Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 104: Japan Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
  • Figure 105: Japan Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
  • Figure 106: Japan Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
  • Figure 107: Japan Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
  • Figure 108: India Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 109: India Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
  • Figure 110: India Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
  • Figure 111: India Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
  • Figure 112: India Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
  • Figure 113: South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 114: South Korea Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
  • Figure 115: South Korea Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
  • Figure 116: South Korea Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
  • Figure 117: South Korea Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
  • Figure 118: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 119: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
  • Figure 120: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
  • Figure 121: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
  • Figure 122: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
  • Figure 123: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Value, 2020H-2030F (USD Million)
  • Figure 124: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, 2023 (%)
  • Figure 125: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 126: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 127: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 128: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Others, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 129: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 130: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 131: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 132: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 133: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
  • Figure 134: Global Impact of Drivers and Restraints
  • Figure 135: Market Share of Prominent Companies of Percutaneous Transluminal Angioplasty (PTA), 2023 (%)
  • Figure 136: Medtronic PLC Revenues, 2021-2023 (USD Million)
  • Figure 137: Medtronic PLC Revenue , By Business Segments, 2023 (%)
  • Figure 138: Medtronic PLC Revenue , By Geographic Segments, 2023 (%)
  • Figure 139: Terumo Corporation Revenues, 2021-2023 (USD Million)
  • Figure 140: Terumo Corporation Revenue , By Business Segments, 2023 (%)
  • Figure 141: Terumo Corporation Revenue , By Geographic Segments, 2023 (%)
  • Figure 142: Cardinal Health Revenue, 2021-2023 (USD Billion)
  • Figure 143: Cardinal Health Business Segment Revenue, 2023 (%)
  • Figure 144: Cardinal Health Geographical Segment Revenue, 2023 (%)
  • Figure 145: Boston Scientific Revenues, 2021-2023 (USD Million)
  • Figure 146: Boston Scientific Revenues, By Geographic Segments, 2023 (%)
  • Figure 147: Boston Scientific Companies Revenue , By Business Segments, 2023 (%)
  • Figure 148: Teleflex Incorporated Revenues, 2021-2023 (USD Million)
  • Figure 149: Teleflex Incorporated Revenues, By Geographic Segments, 2023 (%)
  • Figure 150: Teleflex Incorporated Revenue , By Business Segments, 2023 (%)
  • Figure 151: Johnson & Johnson Revenues, 2021-2023 (USD Billion)
  • Figure 152: Johnson & Johnson Revenues, By Geographic Segments, 2023 (%)
  • Figure 153: Johnson & Johnson Revenue , By Business Segments, 2023 (%)
  • Figure 154: Abbott Laboratories Revenues, 2021-2023 (USD Million)
  • Figure 155: Abbott Laboratories Revenues, By Geographic Segments, 2023 (%)
  • Figure 156: Abbott Laboratories Revenue , By Business Segments, 2023 (%)
  • Figure 157: Stryker Corporation Revenues, 2021-2023 (USD Million)
  • Figure 158: Stryker Corporation Revenue , By Business Segments, 2023 (%)
  • Figure 159: Stryker Corporation Revenue , By Geographic Segments, 2023 (%)
  • Figure 160: Becton Dickinson and Co Revenues, 2021-2023 (USD Billion)
  • Figure 161: Becton Dickinson and Co Revenue , Product Sales By Business Segments, 2023 (%)
  • Figure 162: Becton Dickinson and Co Revenue , By Geographical Segments, 2023 (%)

List of Tables

Table A1: Global Impact of Macro Economic Factors, By Region

Table A2: United States Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A3: United States Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A4: United States Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A5: United States Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A6: United States Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A7: United States Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A8: Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A9: Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A10: Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A11: Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A12: Canada Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A13: Canada Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A14: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A15: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A16: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A17: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A18: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A19: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A20: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A21: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A22: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A23: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A24: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A25: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A26: Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A27: Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A28: Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A29: Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A30: Germany Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A31: Germany Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A32: France Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A33: France Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A34: France Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A35: France Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A36: France Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A37: France Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A38: Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A39: Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A40: Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A41: Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A42: Spain Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A43: Spain Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A44: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A45: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A46: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million

Table A47: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A48: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A49: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A50: China Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A51: China Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A52: China Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A53: China Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A54: China Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A55: China Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A56: Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A57: Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A58: Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A59: Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A60: Japan Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A61: Japan Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A62: India Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A63: India Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A64: India Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A65: India Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A66: India Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A67: India Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A68: South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A69: South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A70: South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A71: South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A72: South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A73: South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A74: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A75: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A76: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A77: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A78: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A79: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A80: Medtronic PLC Key Company Financials, 2021-2023

Table A81: Terumo Corporation Key Company Financials, 2021-2023

Table A82: Cardinal Health Key Company Financials, 2021-2023

Table A83: Boston Scientific Key Financials, 2021-2023

Table A84: Teleflex Incorporated Key Financials, 2021-2022

Table A85: Johnson & Johnson Key Financials, 2021-2023

Table A86: Abbott Laboratories Key Financials, 2021-2023

Table A87: Stryker Corporation Key Company Financials, 2021-2023

Table A88: Becton Dickinson Key Company Financials, 2021-2023